Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Gilberto Amorim"'
Autor:
Luciana Castro Garcia Landeiro, Tamie de Camargo Martins, Ruth Bartelli Grigolon, Isabel Monteiro, Joana Bisol Balardin, Eduardo Padilha, Gilberto Amorim, Stephen Stefani
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
IntroductionBreast cancer (BC) is one of the leading causes of cancer and is the first cause of death from malignant tumors among women worldwide. New cancer therapies receive regulatory approval yearly and to avoid health disparities in society, the
Externí odkaz:
https://doaj.org/article/4658c43d9b634fe9a44fd94670a6fb0d
Autor:
Maria Amelia Carlos Souto Maior Borba, Paula de Mendonça Batista, Milena Falcão Almeida, Maria Aparecida do Carmo Rego, Fernando Brandão Serra, Julio Cesar Barbour Oliveira, Karina Nakajima, Guilherme Silva Julian, Gilberto Amorim
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract In Brazil, data on the management of triple negative breast cancer (TNBC) as well as the burden of the disease in terms of health care resources utilization (HCRU) are scarce. To characterize the treatment patterns and HCRU associated with t
Externí odkaz:
https://doaj.org/article/6be4c685ca6a4defa1d59286a1a498b6
Autor:
Tamie de Camargo Martins, Ruth B Grigolon, Isabel Monteiro, Joana Bisol Balardin, Eduardo Padilha, Gilberto Amorim, Stephen Stefani, Luciana Castro Garcia Landeiro
Publikováno v:
Jornal de Assistência Farmacêutica e Farmacoeconomia, Vol 8, Iss s. 2 (2023)
Introdução: O câncer de mama (CM) é um dos tipos de câncer mais prevalentes e é a primeira causa de morte por tumores malignos entre as mulheres em todo o mundo. Novas terapias recebem aprovação regulatória anualmente, e os sistemas de saúd
Externí odkaz:
https://doaj.org/article/afae0c71c5da4ca292abb111b35ed795
Autor:
Daniela Dornelles Rosa, Carlos Alberto da Silva Magliano, Sergio D. Simon, Gilberto Amorim, Tomás Reinert, Luciana Landeiro, Débora de Melo Gagliato, Pedro Exman, Daniel Argolo, Gisah Guilgen, Max Mano, Laura Testa, Pedro Liedke, Romualdo Barroso, Mariana Sasse, Anna Maria Buehler
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Introduction: The MONALEESA-7 trial compared ribociclib plus endocrine therapy (ET) with placebo as first-line treatment of advanced luminal/HER2-negative breast cancer (ABC) in premenopausal and perimenopausal women (age
Externí odkaz:
https://doaj.org/article/e0b0a8ad353547b5a61531c64ff7af17
Autor:
Francisco Pimentel Cavalcante, Edson Abdala, Leonardo Weissmann, Carlos Eduardo dos Santos Ferreira, Gilberto Amorim, Vilmar Marques de Oliveira, Gisah Guilgen, Luciana Landeiro, João Renato Rebello Pinho, Álvaro Pulchinelli, Heber Ribeiro, Rafael Souza, Daniela Dornelles Rosa
Publikováno v:
JCO Global Oncology, Vol , Iss 8 (2022)
PURPOSEAn expert panel on breast cancer and COVID-19 disease was convened to address the impact of the COVID-19 pandemic for early breast cancer (eBC) management.METHODSTo ensure that the most clinically relevant information was addressed, essential
Externí odkaz:
https://doaj.org/article/b9a0483574cd4a099aa0426221137276
Autor:
Márcio Debiasi, Tomás Reinert, Rafael Kaliks, Gilberto Amorim, Maira Caleffi, Carlos Sampaio, Gustavo dos Santos Fernandes, Carlos H. Barrios
Publikováno v:
Journal of Global Oncology, Vol 3, Iss 3, Pp 201-207 (2017)
Purpose: Patients with human epidermal growth factor receptor 2 (HER2) -positive metastatic tumors treated in the public health system in Brazil do not have access to trastuzumab. This study aimed to estimate the impact of the lack of access to anti-
Externí odkaz:
https://doaj.org/article/fb845d475b4c4e03ac72f598fb8983ea
Neste estudo, que se alicerçou nos pressupostos das teorias da Identidade Social e da Autocategorização, de onde resultam o modelo da Dinâmica de Grupos subjetiva e o conceito de Desidentificação, analisou-se o padrão da identificação grupal
Externí odkaz:
https://hdl.handle.net/10216/123826
Autor:
Francisco Pimentel Cavalcante, Edson Abdala, Leonardo Weissmann, Carlos Eduardo dos Santos Ferreira, Gilberto Amorim, Gustavo Aguiar Campana, Vilmar Marques de Oliveira, Gisah Guilgen, Luciana Landeiro, João Renato Rebello Pinho, Álvaro Pulchinelli Jr, Heber Ribeiro, Rafael Souza, Daniela Dornelles Rosa
Purpose: An Expert Panel on Breast Cancer and COVID-19 was convened to address the impact of the COVID-19 pandemic for early breast cancer management. Methods: In order to ensure the most clinically relevant information was addressed, essential infor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f7966e847b1b1f27c72f9dd1c0e9ece
https://doi.org/10.22541/au.162430528.81312830/v1
https://doi.org/10.22541/au.162430528.81312830/v1
Autor:
T. Bachelot, E. Ciruelos, A. Schneeweiss, F. Puglisi, T. Peretz-Yablonski, I. Bondarenko, S. Paluch-Shimon, A. Wardley, J.-L. Merot, Y. du Toit, V. Easton, N. Lindegger, D. Miles, Kamel Bouzid, Mario Campone, Bruno Coudert, Zbigniew Nowecki, Hassan Errihani, Florence Dalenc, Ana Ferreira, Max Mano, Francesco Ricci, Haralabos Kalofonos, Claudia Andreetta, Filippo Montemurro, Sophie Barrett, Qingyuan Zhang, Dimitris Mavroudis, Juan Matus, Carlos Beato, Xichun Hu, Rabab Gaafar, Hamdy Abdel Azeem, Christophe Perrin, Johannes Ettl, Istvan Lang, Sunil Verma, Huiping Li, Etienne Brain, Oliver Hoffmann, Anna Cariello, Carlo Tondini, Taher Altwegeiri, Niklas Loman, Michael Lux, Antonio Frassoldati, Zeba Aziz, Fernando Salas, Joanna Streb, Andrzej Wronski, Salomón Menjón Beltrán, Irfan Cicin, Peter Schmid, Robert Laing, Zhongsheng Tong, Katalin Boer, Balazs Juhasz, Luca Gianni, Giuseppe Curigliano, Alejandro Juarez, Snezana Susnjar, Erika Matos, Ruchan Uslu, Hans Wildiers, Marcelo Cruz, Hugues Bourgeois, Raquel von Schumann, Salomón Stemmer, Flavia Morales Vásquez, Adriana Dominguez, Marek Wojtukiewicz, Jasna Trifunovic, Jose Juan Illarramendi, Laura Garcia, Yann Izarzugaza Peron, Maria Jose Echarri, Natliia Voitko, Duncan Wheatley, Simon Waters, Richard De Boer, Guy Jerusalem, Véronique Cocquyt, Carlos Barrios, Lawrence Panasci, Johanna Mattson, Minna Tanner, Michel Gozy, Georgios Vasilopoulos, Janos Revesz, Luciano Latini, Cesare Gridelli, Jesus Lazaro, Antonio Gonzalez, Agusti Barnadas Molins, Eduardo Martinez, Jesús Alarcón, Ana Arance, Leif Klint, Oleksiy Kovalyov, Richard Baird, Belinda Yeo, Nicole McCarthy, Richard Greil, Shusen Wang, Xavier Artignan, Paule Augereau, Ingolf Juhasz-Boess, Roger Ngan, Hadassah Goldberg, Francesco Di Costanzo, Francesco Ferraù, Eduardas Aleknavicius, Kamran Rashid, Luís Costa, Jose Angel Garcia, Luis Ruiz de la Cruz, Rafael López López, Olga Del Val, Ozgur Ozyilkan, Fathi Azribi, Mark Verrill, Nicholas Turner, Jane Beith, Andreas Petzer, Jurandyr Andrade, Vanessa Bernstein, Daniel Rayson, Ibtessam Saad Eldin, Mihaëla Achille, Volkmar Mueller, Alessandra Gennari, Stefano Cascinu, Marwan Ghosn, Nagi El-Saghir, Joan Van den Bosch, Rianne Oosterkamp, Monika Kukulska, Ignacio Pelaez, Carolina Hernandez, Maria del Mar Gordon, Elsa Dalmau, Jose Luis Alonso, Sercan Aksoy, Hasan Senol Coskun, Yaroslav Shparyk, Mohini Varughese, Udaiveer Panwar, Lisa Barraclough, Nicola Levitt, Jonathan Hicks, Anna Rigg, Mark Allen, Cecila Castillo, Luis Enrique Fein, Robin Stuart-Harris, Christian Singer, Herbert Stoeger, Sasha Smiljanic, Jifeng Feng, Miguel Cedeño, Jean Francois Berdah, Hubert Orfeuvre, Anthony Goncalves, Eva-Maria Grischke, Eike Simon, Steffen Wagner, Anna Efremidou, Konstantinos Papazisis, Ella Evron, Moshe Inbar, Noa Ben Baruch, David Geffen, Natalya Karminsky, Enzo Maria Ruggeri, Cavanna Luigi, Donatella Grasso, Elona Juozaityte, Jeronimo Rafael Rodriguez Cid, Henk Roerdink, Neelum Siddiqi, José Luís Passos Coelho, Elisa Garcia Garre, Andres Garcia, Noelia Martínez Jañez, Maria Helena Lopez Ceballos, Mireia Mele, María García, Alberto Arcediano, Karen McAdam, Timothy Perren, Wendy Taylor, Alison Humphreys, Raul Vera, Luis Alberto Kaen, Günther Steger, Johannes Andel, Jacques de Grève, Manon Huizing, Roberto Hegg, Anil Joy, Sandeep Sehdev, Riina Kütner, Johanna Ruohola, Nadine Dohollou, Jessica Grosjean, Philippe Laplaige, Rémy Largillier, Philippe Martin, Virginie Pottier, Jerome Alexandre, Bernd Christensen, Dirk-Michael Zahm, Fariba Khandan, Hans-Joachim Lueck, Georgios Fountzilas, Georgeta Fried, Alice Giacobino, Andrea Bonetti, Yanin Chavarri Guerra, Laurens Van Warmerdam, Annette Van der Velden, Suzan Vrijaldenhoven, Felix de Jongh, Milagros Cavero, Raquel Andres Conejero, Adolfo Murias, Salvador Saura, Amparo Oltra, Andres Redondo, Nuria Ribelles, Kilian Bachmeier, Johnathan Joffe, Prabir Chakraborti, Mark Beresford, Mohammad Butt, Christopher Poole, Gassan Yordi, Natasha Woodward, Gilberto Amorim, Nadia Califaretti, Susan Fox, Andre Robidoux, NanLi Li, Nenxiao Li, Jun Jiang, Tannia Soria, Peeter Padrik, Outi Saarni, Dominique Genet, Stéphanie Catala, Hugues Barletta, Luis Teixeira, Thomas Facchini, Tobias Hesse, Thorsten Kühn, Angelika Ober, Roland Repp, Willibald Schroeder, Dimitrios Pectasides, Gyorgy Bodoky, Zsuzsanna Kahan, Irina Jiveliouk, Ora Rosengarten, Oscar Alabiso, Mario Perez, Yes Van de Wouw, Jolanta Smok-Kalwat, Margarida Damasceno, Gabriela Sousa, Omalkhair Abulkhair, Antonio Antón Torres, Maria Purificación Martinez, Jesús Garcia Mata, Marta Santisteban Jesús Florián Jerico, Antonio Llombart, Rosa Sanchez, Juan Carlos Torrego, Clara Olier Garate, Cesar Rodriguez, Rosa Llorente, Diego Soto de Prado, Javier Cortés, Cristina Llorca, Antonio Galán, Gemma Viñas Villaro, Ulrik Narbe, Helena Granstam Bjömeklett, Sarah Westwell, Jackie Newby, Mariam Jafri, Robinson Rodríguez, Isabel Alonso
Background Pertuzumab combined with trastuzumab and docetaxel is the standard first-line therapy for HER2-positive metastatic breast cancer, based on results from the phase III CLEOPATRA trial. PERUSE was designed to assess the safety and efficacy of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7394dbd3f670d60bcbd805c7b372138
https://hdl.handle.net/20.500.14017/e2dbbab9-c685-4110-8d14-e0e540d6de6b
https://hdl.handle.net/20.500.14017/e2dbbab9-c685-4110-8d14-e0e540d6de6b
Autor:
Gilberto Amorim, Irene Biasoli, Maria de Fátima Dias Gaui, Denise Moreira, Célia Djahjah, Guilherme Pereira, Roberto Alfonso Arcuri, Nelson Spector
Publikováno v:
American Journal of Clinical Oncology. 30:78-81
According to data from Brazil's National Cancer Institute nearly 30% of the new patients who present with breast cancer have locally advanced disease. These patients are inoperable and tumor reduction is usually attempted with chemotherapy. First-lin